Covid19
Showing NaN - NaN of 15
SARS-CoV Infection, Covid19 Trial in Mexico, Puerto Rico, United States (SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination
Active, not recruiting
- SARS-CoV Infection
- Covid19
- SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination Period)
- +5 more
-
Birmingham, Alabama
- +155 more
Dec 16, 2022
Covid19 Trial in Brazil, United States (Remdesivir, Remdesivir Placebo, Aviptadil)
Completed
- Covid19
- Remdesivir
- +4 more
-
Tucson, Arizona
- +39 more
Dec 16, 2022
Covid19 Trial in United States (Apixaban 2.5 MG, Placebo)
Active, not recruiting
- Covid19
- Apixaban 2.5 MG
- Placebo
-
Phoenix, Arizona
- +120 more
Jul 1, 2022
Covid19 Trial in Worldwide (theraputic heparin, prophylactic heparin, P2Y12)
Recruiting
- Covid19
- theraputic heparin
- +4 more
-
Birmingham, Alabama
- +101 more
Jun 28, 2022
COVID19 Trial in United States (RD-X19, Sham)
Completed
- COVID19
- RD-X19
- Sham
-
Clearwater, Florida
- +8 more
Apr 13, 2022
Covid19 Trial in Worldwide (Sotrovimab (Gen1), Sotrovimab (Gen2))
Active, not recruiting
- Covid19
- Sotrovimab (Gen1)
- Sotrovimab (Gen2)
-
Anniston, Alabama
- +30 more
Feb 4, 2022
Covid19 Trial in United States (COVI-DROPS, Placebo)
Completed
- Covid19
- COVI-DROPS
- Placebo
-
Colorado Springs, Colorado
- +17 more
Jan 21, 2022
Covid19 Trial in United States (Standard of Care, SARS-CoV2-CTLS)
Recruiting
- Covid19
- Standard of Care
- SARS-CoV2-CTLS
-
Valhalla, New York
- +3 more
Jan 10, 2022
